Company: HURA
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0000950170-25-047921
Chunk: 281

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-03-31
Form: 10-K
Item: Item 1B
Chunk 281
---
 an offset to additional paid in capital.Convertible notes and debt discount Convertible notes issued (including accrued interest) outstanding, and converted are as follows: 

        Convertible notespayable

        Balance as of January 1, 2023
         
        $
        -

        Issuance of convertible notes payable

        2,685,000

        Interest expense

        13,564

        Balance as of December 31, 2023
         
        $
        2,698,564

        Issuance of convertible notes payable

        28,568,000

        Interest expense

        2,859,878

        Converted to common stock

        (34,126,442
        )

        Balance as of December 31, 2024
         
        $
        -

       Debt discount related to the convertible notes are as follows: 

F-19

TUHURA BIOSCIENSES, INC AND SUBSIDIARIESNotes to the consolidated financial statementsFor the years ended December 31, 2024, and 2023  

        Debt discount

        Balance as of January 1, 2023
         
        $
        -

        Debt issue costs

        (242,530
        )

        Debt discount associated with make-whole features recognized

        (137,000
        )

        Amortized to interest expense

        5,124

        Balance as of December 31, 2023
         
        $
        (374,406
        )

        Debt issue costs

        (1,218,525
        )

        Debt discount associated with make-whole features recognized

        (2,402,228
        )

        Debt discount associated with warrants recognized

        (6,520,058
        )

        Amortized to interest expense

        1,278,424

        Reclassified to additional paid-in capital upon conversion of convertible notes payable

        9,236,793

        Balance as of December 31, 2024
         
        $
        -

Note 11—Income taxesIncome taxes are provided for the tax effects of transactions reported in the financial statements and consist of taxes currently due. Deferred taxes relate to differences between the basis of assets and liabilities for financial and income tax reporting which will be either taxable or deductible when the assets or liabilities are recovered or settled.The components of the provision for income taxes are as follows: